First Mercantile Trust’s TherapeuticsMD TXMD Stock Holding History

First Mercantile Trust’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,833	Closed	-$222K	–	903
2019 Q4	$222K	Buy	1,833 +246	+16%	+$35.4K	0.03%	423
2019 Q3	$288K	Sell	1,587 -47	-3%	-$6.63K	0.03%	371
2019 Q2	$212K	Buy	1,634 +1,064	+187%	+$191K	0.02%	421
2019 Q1	$139K	Buy	+570	New	+$151K	0.03%	577

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Mercantile Trust's TXMD Position: Q1 2020 in Review

First Mercantile Trust sold out of TherapeuticsMD (TXMD) in Q1 2020, closing a stake of 1,833 shares — an estimated $222K sold.

First Mercantile Trust first reported a position in TXMD in Q1 2019 and held it in 4 quarters. The position peaked at $288K in Q3 2019. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

First Mercantile Trust reported no remaining TherapeuticsMD position as of Q1 2020 after selling out during the quarter.
First Mercantile Trust sold 1,833 TherapeuticsMD shares in Q1 2020, an estimated $222K.
First Mercantile Trust first reported a position in TherapeuticsMD in Q1 2019 and held it in 4 quarters.
First Mercantile Trust's TherapeuticsMD position peaked at $288K in Q3 2019.
143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on First Mercantile Trust's 13F filing for Q1 2020, filed 12 May 2020.